---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-22-001328"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2022-06-22T23:59:59+00:00"
generated_at: "2026-06-24T23:55:10.499273+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Lexaria enters manufacturing and license agreements with BevNology for DehydraTECH CBD tech

## Summary
- Manufacturing operating agreement for fee-based production of DehydraTECH-enabled APIs for corporate clients.
- Five-year global non-exclusive license for hemp CBD (<0.3% THC) in bulk powders, liquids, and finished consumer products.
- Exclusions: Japan, South Korea, China; limited exclusive US rights for bulk liquids subject to minimum fee.
- No financial terms disclosed; agreements described as non-material.

## SEC filing metadata
- accession: 0001640334-22-001328
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2022-06-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033422001328/0001640334-22-001328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033422001328/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-22-001328
- JSON: https://secwatch.observer/filing/0001640334-22-001328.json
- Plain text: https://secwatch.observer/filing/0001640334-22-001328.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.